Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune dysregulation in asthma.

Dale T Umetsu1, Rosemarie H Dekruyff

  • 1Division of Immunology, Children's Hospital Boston, Harvard Medical School, Karp Laboratories, Rm 10127, One Blackfan Circle, Boston, MA 02115, USA. dale.umetsu@childrens.harvard.edu

Current Opinion in Immunology
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: A new era in the treatment of food allergy.

Frontiers in immunology·2026
Same author

Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness.

Nature immunology·2025
Same author

Single cell multi-omic analysis identifies key genes differentially expressed in innate lymphoid cells from COVID-19 patients.

Frontiers in immunology·2024
Same author

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH).

The journal of allergy and clinical immunology. Global·2023
Same author

Immunoregulatory effects of RGMb in gut inflammation.

Frontiers in immunology·2022
Same author

Understanding microorganisms in the prevention of allergy.

Nature immunology·2022

Allergic diseases stem from immune system imbalances. Inducing allergen-specific regulatory T cells may offer a cure for allergies and asthma by restoring immune tolerance.

Area of Science:

  • Immunology
  • Allergy Research
  • Asthma Pathogenesis

Background:

  • Allergic diseases and asthma arise from aberrant T helper 2 (Th2)-biased immune responses to environmental allergens in susceptible individuals.
  • Recent advancements have elucidated the mechanisms of Th2 response generation and the role of natural killer T cells in asthma.
  • Understanding allergen tolerance, regulatory T cells (Tregs), and therapeutic strategies for allergic conditions has significantly progressed.

Purpose of the Study:

  • To review the current understanding of Th2-biased immune responses in allergic diseases and asthma.
  • To explore the role of natural killer T cells and regulatory T cells in the pathogenesis and potential treatment of asthma.
  • To discuss strategies for preventing or reversing allergic diseases through immune modulation.

Related Experiment Videos

Main Methods:

  • Literature review of recent research on Th2 immunity, T cells, and allergen tolerance.
  • Analysis of studies investigating the mechanisms of Th2 polarization and Treg function.
  • Synthesis of findings related to therapeutic interventions targeting regulatory T cells for allergic diseases.

Main Results:

  • Dysregulated Th2 responses are central to allergy and asthma development.
  • Natural killer T cells play a pathogenic role in asthma.
  • Allergen-specific regulatory T cells are crucial for immune tolerance and hold therapeutic potential.

Conclusions:

  • Impaired expansion of regulatory T cells is a key factor in allergy and asthma development.
  • Inducing allergen-specific regulatory T cells presents a promising curative therapy for allergic diseases and asthma.
  • Further research into Treg induction is vital for developing effective treatments.